help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasegawa, N.
Right arrow Articles by Raffin, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasegawa, N.
Right arrow Articles by Raffin, T. A.

Am. J. Respir. Crit. Care Med., Vol 153, No. 6, 06 1996, 1831-1837.

The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats

N Hasegawa, TG Kandra, AW Husari, S Veiss, WT Hart, J Hedgpeth, R Wydro and TA Raffin
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305-5236, USA.

Activation of the coagulation system is postulated to play an important role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin (TM) is an endothelial cell membrane glycoprotein receptor for thrombin. Once bound to TM, thrombin loses its procoagulant activity, which results in decreased clotting. In addition, the binding of thrombin to TM activates the endogenous anticoagulant pathway through protein C. We studied the effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg of rh-TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection of 20 mg/kg of Escherichia coli endotoxin. The study presented here consisted of three separate experiments. Experiment 1: 24-h survival study. Experiment 2: multiple-system organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotoxin or saline injection and tissue microthrombi formation was assessed by measuring the percentage of organ radioactivity (lung, heart, liver, and kidney) against total injected radioactivity (microthrombi index, MI) 2.25 h after an endotoxin or saline injection. Experiment 3: endotoxin-induced MSOF study in which 125I-rat albumin was injected 5 h after an endotoxin or saline injection, and endotoxin-induced organ injury was evaluated by measuring tissue wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration ratios (T/P) 8 h after the endotoxin or saline injection. Blood contamination in samples from Experiments 2 and 3 was corrected by using 131I-rat albumin measurements. Pretreatment with rh-TM improved the survival from 12 h through 23 h as compared with that of the endotoxin control group (p < 0.05). However, at 24 h, after essentially all injected rh-TM had been eliminated, there was no difference in survival. Significant reductions in MI, W/D, and T/P in the organs sampled were observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM improved short-term but not overall survival and decreased MSOF in endotoxemic rats.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
T. Ozaki, C. Anas, S. Maruyama, T. Yamamoto, K. Yasuda, Y. Morita, Y. Ito, M. Gotoh, Y. Yuzawa, and S. Matsuo
Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 110 - 119.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Weijer, C. W. Wieland, S. Florquin, and T. van der Poll
A thrombomodulin mutation that impairs activated protein C generation results in uncontrolled lung inflammation during murine tuberculosis
Blood, October 15, 2005; 106(8): 2761 - 2768.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Suzuki, Y. Muto, K. Fushihara, K.-i. Kanemoto, H. Iida, E. Sato, C. Kikuchi, T. Matsushima, E. Kato, M. Nomoto, et al.

J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 607 - 615.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. W. Rijneveld, S. Weijer, S. Florquin, C. T. Esmon, J. C. M. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide
Blood, March 1, 2004; 103(5): 1702 - 1709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al.
Platelets inhibit the lysis of pulmonary microemboli
Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L529 - L539.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C. C. Solomides, G. G. Pietra, J.-C. Murciano, S. A. Shah, H. Ischiropoulos, S. M. Albelda, et al.
Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury : Targeting to Thrombomodulin, But Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration
Am. J. Pathol., March 1, 2002; 160(3): 1155 - 1169.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. B. Taylor Jr, D. J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A. C. K. Chang, Z. Laszik, S. Kosanke, G. Peer, and C. T. Esmon
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
Blood, March 1, 2000; 95(5): 1680 - 1686.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society